PARIS, February 6 /PRNewswire/ -- Aureus Pharma a leading provider of knowledge management solutions to aid discovery in the life sciences industry, today announces that GlaxoSmithKline (GSK) has signed a multi-year license for Aureus Pharma's AurSCOPE Knowledge databases. Researchers at GSK's global research and development centers will gain access to Aureus' Knowledge databases including AurSCOPE GPCR, Ion Channel, hERG, and ADME/Drug-Drug Interactions. In addition, GSK has licensed the recently released AurSCOPE Kinase product making it the first customer of this knowledge base which is of major importance for oncology and other diseases. Financial details were not disclosed.
"AurSCOPE knowledge databases are comprised of detailed quantitative biological and chemical data. With its unrivalled level of quality, Aureus Pharma's knowledge driven discovery platform provides drug discovery teams with comprehensive information to accelerate both the drug discovery and development process," said Dr. Andre Michel, CEO of Aureus Pharma, "We are pleased that GSK has selected Aureus Pharma as their global solution provider of integrated knowledge databases."
The addition of a pharmaceutical R&D world leader, such as GSK, to Aureus' growing list of customers is further confirmation that AurSCOPE is becoming accepted as the knowledge base of choice for pharmaceutical and biotechnology organizations.
About Aureus Pharma
Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit www.aureus-pharma.com
Contact: Mary E. Donlan, Ph.D Director of Marketing & Sales +33-6-76-19-51-77 mary.donlan@aureus-pharma.com
Aureus PharmaCONTACT: Contact: Mary E. Donlan, Ph.D, Director of Marketing & Sales,+33-6-76-19-51-77, mary.donlan@aureus-pharma.com
